MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA from the 12S rRNA region. Discovered in 2015, it represents a unique class of molecules that can translocate to the nucleus under stress conditions to regulate gene expression.
Key characteristics:
Encoded by mitochondrial DNA, not nuclear DNA
Declines with age (21% reduction in elderly vs. young adults)
Can move from mitochondria to nucleus to regulate genes
How MOTS-c Works
MOTS-c regulates metabolism through several mechanisms:
AMPK Activation: Activates the master energy sensor, leading to:
Improved insulin sensitivity
Enhanced glucose metabolism
Increased fat oxidation
Nuclear Gene Regulation: Under stress, translocates to nucleus and:
Activates antioxidant response elements
Regulates PGC-1alpha and SIRT1
Enhances mitochondrial protection via NRF2/ARE pathway
Exercise Mimetic: Increases with physical activity and:
Improves physical performance across all ages
Works synergistically with exercise training
Activates similar pathways as regular workouts
Therapeutic Applications
MOTS-c demonstrates therapeutic potential across four major categories of age-related diseases:
Metabolic Disorders: Enhances insulin sensitivity in both type 1 and type 2 diabetes, reduces glucose and insulin levels in obesity models, and decreases oxidative stress markers.
Cardiovascular Disease: Protects against endothelial dysfunction and vascular calcification while reducing pro-inflammatory cytokines. May serve as a biomarker for coronary dysfunction.
Musculoskeletal Health: Stimulates bone formation via TGF-beta/SMAD pathway, prevents postmenopausal bone loss, and increases brown fat activation to limit weight gain.
Neurodegenerative Disease: Improves memory formation in Alzheimer's models, reduces neuroinflammation, and decreases astrocyte and microglia activation.
Longevity Connections
MOTS-c intersects with established longevity pathways:
Elevates NAD+ levels (key anti-aging molecule)
Activates sirtuins (aging regulators)
Mimics methionine restriction (extends lifespan 45% in mice)
Enhances mitochondrial function and reduces oxidative damage
Clinical Implications
Current status and future directions:
Research Stage: Most studies conducted in animal models
Potential Applications: Treatment for metabolic disorders, disease biomarker, exercise adjunct
Practical Action: Regular exercise naturally boosts MOTS-c production
MOTS-c represents a paradigm shift in understanding mitochondrial function and aging, bridging mitochondrial metabolism with genomic stress responses.
Reference
Mohtashami, Z., Singh, M.K., Salimiaghdam, N., Ozgul, M., & Kenney, M.C. (2022). MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. International Journal of Molecular Sciences, 23(19), 11991. https://doi.org/10.3390/ijms231911991
Disclaimer: This article is for educational and academic purposes only and does not constitute medical advice. Any medication treatment should be conducted under the guidance of a qualified healthcare professional.
MOTS-c: A Mitochondrial Peptide for Healthy Aging
What is MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA from the 12S rRNA region. Discovered in 2015, it represents a unique class of molecules that can translocate to the nucleus under stress conditions to regulate gene expression.
Key characteristics:
How MOTS-c Works
MOTS-c regulates metabolism through several mechanisms:
AMPK Activation: Activates the master energy sensor, leading to:
Nuclear Gene Regulation: Under stress, translocates to nucleus and:
Exercise Mimetic: Increases with physical activity and:
Therapeutic Applications
MOTS-c demonstrates therapeutic potential across four major categories of age-related diseases:
Metabolic Disorders: Enhances insulin sensitivity in both type 1 and type 2 diabetes, reduces glucose and insulin levels in obesity models, and decreases oxidative stress markers.
Cardiovascular Disease: Protects against endothelial dysfunction and vascular calcification while reducing pro-inflammatory cytokines. May serve as a biomarker for coronary dysfunction.
Musculoskeletal Health: Stimulates bone formation via TGF-beta/SMAD pathway, prevents postmenopausal bone loss, and increases brown fat activation to limit weight gain.
Neurodegenerative Disease: Improves memory formation in Alzheimer's models, reduces neuroinflammation, and decreases astrocyte and microglia activation.
Longevity Connections
MOTS-c intersects with established longevity pathways:
Clinical Implications
Current status and future directions:
MOTS-c represents a paradigm shift in understanding mitochondrial function and aging, bridging mitochondrial metabolism with genomic stress responses.
Reference
Mohtashami, Z., Singh, M.K., Salimiaghdam, N., Ozgul, M., & Kenney, M.C. (2022). MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. International Journal of Molecular Sciences, 23(19), 11991. https://doi.org/10.3390/ijms231911991
Disclaimer: This article is for educational and academic purposes only and does not constitute medical advice. Any medication treatment should be conducted under the guidance of a qualified healthcare professional.